Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions

Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis. Patients with underlying health conditions are vulnerable to invasive fungal in...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports 2021-10, Vol.9 (10), p.e05009-n/a
Main Authors: Heydarifard, Zahra, Safaei, Moslem, Zadheidar, Sevrin, Ehsan, Soroush, Shafiei‐Jandaghi, Nazanin Zahra
Format: Article
Language:English
Subjects:
Bacterial infections
Case Report
Case reports
Coronaviruses
COVID-19
Creatinine
Debridement
Dehydrogenases
Diabetes
Hematology
Hemodialysis
Histopathology
Hospitalization
Hypertension
Infections
Magnetic resonance imaging
mucormycosis
Patients
Pneumonia
SARS‐CoV‐2
Severe acute respiratory syndrome coronavirus 2
severe COVID‐19
Sinuses
underlying health conditions
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4769-ac2e34ebca0895fba779d6804e44795bd8d5df54e0006795ea3270b0993967c33
cites cdi_FETCH-LOGICAL-c4769-ac2e34ebca0895fba779d6804e44795bd8d5df54e0006795ea3270b0993967c33
container_end_page n/a
container_issue 10
container_start_page e05009
container_title Clinical case reports
container_volume 9
creator Heydarifard, Zahra
Safaei, Moslem
Zadheidar, Sevrin
Ehsan, Soroush
Shafiei‐Jandaghi, Nazanin Zahra
description Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis. Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis.
doi_str_mv 10.1002/ccr3.5009
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_cb800dc93e534d55922e65f5b9af7166</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_cb800dc93e534d55922e65f5b9af7166</doaj_id><sourcerecordid>2605072078</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4769-ac2e34ebca0895fba779d6804e44795bd8d5df54e0006795ea3270b0993967c33</originalsourceid><addsrcrecordid>eNp1kc9u1DAQhyMEolXpgRdAkThx2Hbiv_EFCaVQViqqhIAjlmNPdr3KxoudtNobj8Az9knwdpeqPXDyaObT5xn9iuJ1BWcVADm3NtIzDqCeFccEOMxAAXv-qD4qTlNaAUAFkvAKXhZHlEnGBamOi59fJhviemtD8qn0Q4d29GHIVZnwBiOWzfWP-cXd7z-VKjdm9DiM5a0fl-V66ke_6bGcBoex3_phUS7R9Hlkw-D8TpNeFS860yc8PbwnxfdPH781n2dX15fz5sPVzDIp1MxYgpRhaw3UinetkVI5UQNDxqTirasddx1nmK8QuYGGEgktKEWVkJbSk2K-97pgVnoT_drErQ7G6_tGiAtt4uhtj9q2NYCziiKnzHGuCEHBO94q08lKiOx6v3dtpnaNzuaLo-mfSJ9OBr_Ui3Cja84JyDoL3h4EMfyaMI16FaY45Ps1ETkVeaDe7SkbQ0oRu4cfKtC7ZPUuWb1LNrNvHq_0QP7LMQPne-DW97j9v0k3zVd6r_wL03euKQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2605072078</pqid></control><display><type>article</type><title>Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions</title><source>Publicly Available Content Database</source><source>Wiley Open Access</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Heydarifard, Zahra ; Safaei, Moslem ; Zadheidar, Sevrin ; Ehsan, Soroush ; Shafiei‐Jandaghi, Nazanin Zahra</creator><creatorcontrib>Heydarifard, Zahra ; Safaei, Moslem ; Zadheidar, Sevrin ; Ehsan, Soroush ; Shafiei‐Jandaghi, Nazanin Zahra</creatorcontrib><description>Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis. Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis.</description><identifier>ISSN: 2050-0904</identifier><identifier>EISSN: 2050-0904</identifier><identifier>DOI: 10.1002/ccr3.5009</identifier><identifier>PMID: 34745621</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Bacterial infections ; Case Report ; Case reports ; Coronaviruses ; COVID-19 ; Creatinine ; Debridement ; Dehydrogenases ; Diabetes ; Hematology ; Hemodialysis ; Histopathology ; Hospitalization ; Hypertension ; Infections ; Magnetic resonance imaging ; mucormycosis ; Patients ; Pneumonia ; SARS‐CoV‐2 ; Severe acute respiratory syndrome coronavirus 2 ; severe COVID‐19 ; Sinuses ; underlying health conditions ; Veins &amp; arteries</subject><ispartof>Clinical case reports, 2021-10, Vol.9 (10), p.e05009-n/a</ispartof><rights>2021 The Authors. published by John Wiley &amp; Sons Ltd.</rights><rights>2021 The Authors. Clinical Case Reports published by John Wiley &amp; Sons Ltd.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4769-ac2e34ebca0895fba779d6804e44795bd8d5df54e0006795ea3270b0993967c33</citedby><cites>FETCH-LOGICAL-c4769-ac2e34ebca0895fba779d6804e44795bd8d5df54e0006795ea3270b0993967c33</cites><orcidid>0000-0002-2093-819X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2605072078/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2605072078?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,38516,43895,44590,46052,46476,53791,53793,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34745621$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Heydarifard, Zahra</creatorcontrib><creatorcontrib>Safaei, Moslem</creatorcontrib><creatorcontrib>Zadheidar, Sevrin</creatorcontrib><creatorcontrib>Ehsan, Soroush</creatorcontrib><creatorcontrib>Shafiei‐Jandaghi, Nazanin Zahra</creatorcontrib><title>Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions</title><title>Clinical case reports</title><addtitle>Clin Case Rep</addtitle><description>Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis. Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis.</description><subject>Bacterial infections</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Creatinine</subject><subject>Debridement</subject><subject>Dehydrogenases</subject><subject>Diabetes</subject><subject>Hematology</subject><subject>Hemodialysis</subject><subject>Histopathology</subject><subject>Hospitalization</subject><subject>Hypertension</subject><subject>Infections</subject><subject>Magnetic resonance imaging</subject><subject>mucormycosis</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>SARS‐CoV‐2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>severe COVID‐19</subject><subject>Sinuses</subject><subject>underlying health conditions</subject><subject>Veins &amp; arteries</subject><issn>2050-0904</issn><issn>2050-0904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kc9u1DAQhyMEolXpgRdAkThx2Hbiv_EFCaVQViqqhIAjlmNPdr3KxoudtNobj8Az9knwdpeqPXDyaObT5xn9iuJ1BWcVADm3NtIzDqCeFccEOMxAAXv-qD4qTlNaAUAFkvAKXhZHlEnGBamOi59fJhviemtD8qn0Q4d29GHIVZnwBiOWzfWP-cXd7z-VKjdm9DiM5a0fl-V66ke_6bGcBoex3_phUS7R9Hlkw-D8TpNeFS860yc8PbwnxfdPH781n2dX15fz5sPVzDIp1MxYgpRhaw3UinetkVI5UQNDxqTirasddx1nmK8QuYGGEgktKEWVkJbSk2K-97pgVnoT_drErQ7G6_tGiAtt4uhtj9q2NYCziiKnzHGuCEHBO94q08lKiOx6v3dtpnaNzuaLo-mfSJ9OBr_Ui3Cja84JyDoL3h4EMfyaMI16FaY45Ps1ETkVeaDe7SkbQ0oRu4cfKtC7ZPUuWb1LNrNvHq_0QP7LMQPne-DW97j9v0k3zVd6r_wL03euKQ</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Heydarifard, Zahra</creator><creator>Safaei, Moslem</creator><creator>Zadheidar, Sevrin</creator><creator>Ehsan, Soroush</creator><creator>Shafiei‐Jandaghi, Nazanin Zahra</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2093-819X</orcidid></search><sort><creationdate>202110</creationdate><title>Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions</title><author>Heydarifard, Zahra ; Safaei, Moslem ; Zadheidar, Sevrin ; Ehsan, Soroush ; Shafiei‐Jandaghi, Nazanin Zahra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4769-ac2e34ebca0895fba779d6804e44795bd8d5df54e0006795ea3270b0993967c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Bacterial infections</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Creatinine</topic><topic>Debridement</topic><topic>Dehydrogenases</topic><topic>Diabetes</topic><topic>Hematology</topic><topic>Hemodialysis</topic><topic>Histopathology</topic><topic>Hospitalization</topic><topic>Hypertension</topic><topic>Infections</topic><topic>Magnetic resonance imaging</topic><topic>mucormycosis</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>SARS‐CoV‐2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>severe COVID‐19</topic><topic>Sinuses</topic><topic>underlying health conditions</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heydarifard, Zahra</creatorcontrib><creatorcontrib>Safaei, Moslem</creatorcontrib><creatorcontrib>Zadheidar, Sevrin</creatorcontrib><creatorcontrib>Ehsan, Soroush</creatorcontrib><creatorcontrib>Shafiei‐Jandaghi, Nazanin Zahra</creatorcontrib><collection>Wiley Open Access</collection><collection>Wiley-Blackwell Free Backfiles(OpenAccess)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heydarifard, Zahra</au><au>Safaei, Moslem</au><au>Zadheidar, Sevrin</au><au>Ehsan, Soroush</au><au>Shafiei‐Jandaghi, Nazanin Zahra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions</atitle><jtitle>Clinical case reports</jtitle><addtitle>Clin Case Rep</addtitle><date>2021-10</date><risdate>2021</risdate><volume>9</volume><issue>10</issue><spage>e05009</spage><epage>n/a</epage><pages>e05009-n/a</pages><issn>2050-0904</issn><eissn>2050-0904</eissn><abstract>Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis. Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34745621</pmid><doi>10.1002/ccr3.5009</doi><tpages>0</tpages><orcidid>https://orcid.org/0000-0002-2093-819X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2050-0904
ispartof Clinical case reports, 2021-10, Vol.9 (10), p.e05009-n/a
issn 2050-0904
2050-0904
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_cb800dc93e534d55922e65f5b9af7166
source Publicly Available Content Database; Wiley Open Access; PubMed Central; Coronavirus Research Database
subjects Bacterial infections
Case Report
Case reports
Coronaviruses
COVID-19
Creatinine
Debridement
Dehydrogenases
Diabetes
Hematology
Hemodialysis
Histopathology
Hospitalization
Hypertension
Infections
Magnetic resonance imaging
mucormycosis
Patients
Pneumonia
SARS‐CoV‐2
Severe acute respiratory syndrome coronavirus 2
severe COVID‐19
Sinuses
underlying health conditions
Veins & arteries
title Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A59%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mucormycosis%20infection%20in%20severe%20COVID%E2%80%9019%20patient%20with%20multiple%20underlying%20health%20conditions&rft.jtitle=Clinical%20case%20reports&rft.au=Heydarifard,%20Zahra&rft.date=2021-10&rft.volume=9&rft.issue=10&rft.spage=e05009&rft.epage=n/a&rft.pages=e05009-n/a&rft.issn=2050-0904&rft.eissn=2050-0904&rft_id=info:doi/10.1002/ccr3.5009&rft_dat=%3Cproquest_doaj_%3E2605072078%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4769-ac2e34ebca0895fba779d6804e44795bd8d5df54e0006795ea3270b0993967c33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2605072078&rft_id=info:pmid/34745621&rfr_iscdi=true